Aehr Test Systems AEHR
104.39
6.97
7.15%
as of 25 Sep
- Market cap
- $3.3B
- P/E
- 0.0×
Follow AEHR
| May '26 | Feb '26 | Nov '25 | Aug '25 | Older periods | |
|---|---|---|---|---|---|
| (4.16%) | (8.68%) | (6.97%) | (5.43%) |
+8 more TTM periods Free account |
|
| (3.61%) | (7.54%) | (6.09%) | (4.59%) | ||
ROIC |
(8.57%) | (9.91%) | (8.15%) | (6.21%) | |
Return on Tangible Assets |
(4.06%) | (11.84%) | (9.97%) | (8.20%) | |
Average Days of Receivables |
127.55 | 95.24 | 70.48 | 83.87 | |
Free Cash Flow per Share |
(0.18) | (0.40) | (0.39) | (0.54) | |
Free Cash Flow |
(5.38) | (12.19) | (11.69) | (16.25) | |
Capital Expenditures |
(2.07) | (4.75) | (6.33) | (6.19) | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(0.99%) | (4.24%) | (3.32%) | (6.93%) | |
Accounts Receivable Turnover |
3.16 | 3.80 | 6.05 | 5.26 | |
Accounts Payable Turnover |
4.80 | 6.92 | 8.46 | 8.10 | |
Inventory Turnover |
0.78 | 0.75 | 0.82 | 0.85 | |
Average Days of Payables |
76.20 | 24.48 | 36.45 | 34.04 | |
Days of Inventory on Hand |
466.59 | 479.22 | 438.89 | 421.38 | |
Tax Rate |
(0.39) | (0.20) | (0.20) | (0.16) | |
Research and Development Expense of Revenue |
25.27% | 25.80% | 21.87% | 19.27% | |
Selling, General and Administrative Expense of Revenue |
38.32% | 38.69% | 34.25% | 32.46% | |
Share Based Compensation of Revenue |
13.52% | 13.96% | 12.64% | 10.49% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.46 | 0.65 | 0.61 | 1.51 | |
Depreciation/Fixed assets |
0.39 | 0.40 | 0.41 | 0.42 | |
Capex/Depreciation |
(0.59) | (1.29) | (1.70) | (1.65) | |
Revenue per Share |
1.63 | 1.47 | 1.76 | 1.90 | |
Operating CF per Share |
(0.11) | (0.24) | (0.18) | (0.34) | |
Capex per Share |
(0.07) | (0.15) | (0.21) | (0.21) | |
Capex to Sales |
0.04 | 0.11 | 0.12 | 0.11 | |
Net Profit Margin |
(14.25%) | (25.23%) | (16.63%) | (11.71%) |
Columns are period end dates